21 September 2010
A rare case of fulminant myocarditis succesfully treated with immunoglobulin therapy
Chiara Nalli, Christian Couture, Mathieu Bernier, Sébastien Bergeron, Bernard Cantin, Marie-Hélène Leblanc, Guy Proulx, Mario SénéchalAm J Case Rep 2010; 11:166-168 :: ID: 881158
Abstract
Background: There is much debate over the role of immunosuppression in the treatment of acute fulminant myocarditis. The optimal treatment approach besides standard heart failure therapy and supportive care remains unclear. With conventional supportive therapy, with or without mechanical assist device, myocardial recovery is expected to take weeks to months. This is in contrast to the rapid improvement that can be observed in patients treated with immunotherapy.
Case Report: We report the case of an adult patient with fulminant myocarditis in whom cardiac function normalized within 2 days after high-dose intravenous immunoglobulin therapy (IVIG).
Conclusions: Therapy with IVIG may be a potentially useful treatment in selected patients if given early in the course of this disease. In presence of clinical presentation suggestive of fulminant myocarditis and lymphocytic myocarditis demonstrated by myocardial biopsy, IVIG should be considered.
Keywords: fulminant myocarditis, immunoglobulin therapy
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946011
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945910
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945852
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.944817
Most Viewed Current Articles
21 Jun 2024 : Case report
88,930
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
50,135
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,494
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,670
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030